Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer

Mariana Suaya1,2, Gonzalo Manuel Sánchez1,2, Antonella Vila1,2

  • 1Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales (FCEN), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.

Cell Death & Disease
|October 3, 2022
PubMed

Insights

The AKT and Unfolded Protein Response (UPR) pathways control cell survival and death, crucial in SARS-CoV-2 infection and cancer. Their crosstalk offers a unified target for new antiviral and anticancer therapies, potentially using drug repositioning.

Area of Science:

  • Molecular Biology
  • Virology
  • Oncology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, impacting cell survival and death.
  • The AKT and Unfolded Protein Response (UPR) pathways are vital for cell homeostasis and are implicated in viral infections and cancer.
  • Cancer is a major comorbidity of COVID-19, highlighting the need to understand shared molecular mechanisms.

Purpose of the Study:

  • To review the roles of AKT and UPR pathways in SARS-CoV-2 infection.
  • To examine the involvement of AKT and UPR pathways in cancer development and progression.
  • To explore the crosstalk between AKT and UPR pathways as a potential therapeutic target.

Main Methods:

  • Literature review of existing research on AKT and UPR pathways.
  • Analysis of molecular mechanisms linking these pathways to SARS-CoV-2 infection.
  • Investigation of the pathways' roles in tumorigenesis and progression.

Main Results:

  • The AKT and UPR pathways are deregulated during SARS-CoV-2 infection and in cancer.
  • Evidence suggests a unified homeostatic control system involving crosstalk between AKT and UPR.
  • Feedback regulation between these pathways is a master control of cell fate (survival/death).

Conclusions:

  • The interaction between AKT and UPR pathways is a critical regulator of cell survival and death.
  • This crosstalk represents a promising therapeutic target for both SARS-CoV-2 infection and cancer.
  • Drug repositioning offers a cost-effective strategy for developing treatments targeting these pathways.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
6.7K